B
Bellecapital’s ARK Genomic Revolution ETF ARKG Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $724K | Sell |
29,724
-8,267
| -22% | -$201K | 0.13% | 66 |
|
2025
Q1 | $789K | Sell |
37,991
-272
| -0.7% | -$5.65K | 0.16% | 64 |
|
2024
Q4 | $901K | Sell |
38,263
-35,320
| -48% | -$832K | 0.16% | 63 |
|
2024
Q3 | $1.88M | Sell |
73,583
-1,250
| -2% | -$32K | 0.37% | 46 |
|
2024
Q2 | $1.76M | Buy |
74,833
+10,100
| +16% | +$237K | 0.37% | 47 |
|
2024
Q1 | $1.86M | Buy |
64,733
+3,091
| +5% | +$88.9K | 0.41% | 47 |
|
2023
Q4 | $2.02M | Sell |
61,642
-11,889
| -16% | -$390K | 0.46% | 47 |
|
2023
Q3 | $2.05M | Buy |
73,531
+1,084
| +1% | +$30.2K | 0.51% | 46 |
|
2023
Q2 | $2.47M | Buy |
72,447
+8,724
| +14% | +$297K | 0.6% | 45 |
|
2023
Q1 | $1.92M | Buy |
63,723
+5,380
| +9% | +$162K | 0.48% | 46 |
|
2022
Q4 | $1.65M | Sell |
58,343
-17,192
| -23% | -$485K | 0.46% | 46 |
|
2022
Q3 | $2.48M | Buy |
75,535
+3,981
| +6% | +$131K | 0.76% | 37 |
|
2022
Q2 | $2.25M | Sell |
71,554
-17,312
| -19% | -$545K | 0.63% | 44 |
|
2022
Q1 | $4.08M | Buy |
88,866
+13,961
| +19% | +$641K | 1.29% | 23 |
|
2021
Q4 | $4.59M | Buy |
74,905
+321
| +0.4% | +$19.7K | 1.31% | 24 |
|
2021
Q3 | $5.57M | Buy |
74,584
+6,876
| +10% | +$514K | 1.7% | 19 |
|
2021
Q2 | $6.26M | Sell |
67,708
-7,303
| -10% | -$676K | 1.9% | 16 |
|
2021
Q1 | $6.66M | Sell |
75,011
-15,506
| -17% | -$1.38M | 2.08% | 15 |
|
2020
Q4 | $8.44M | Buy |
+90,517
| New | +$8.44M | 2.82% | 5 |
|